Jin Medical director Xue Ning files insider report

Jin Medical International Ltd. reported insider information for director Xue Ning through an initial beneficial ownership statement.

Accepted by SEC EDGAR 07/16/2026 - 03:12 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Jin Medical International Ltd. reported insider information for director Xue Ning through an initial beneficial ownership statement. The report identifies Ning as a director of Jin Medical but does not list any non-derivative or derivative equity holdings or any insider transactions in the company’s securities as of this filing.

Key Terms

beneficial ownership, Rule 10b5-1 trading plans, derivative positions

3 terms

beneficial ownership financial

"file an initial statement of beneficial ownership of securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Rule 10b5-1 trading plans regulatory

"Footnotes may reference Rule 10b5-1 trading plans or pre-arranged"

Rule 10b5-1 trading plans are written, pre-arranged instructions that allow company insiders (such as executives or directors) to automatically buy or sell their company's stock at specified times or under set conditions, like a standing instruction or automated thermostat for trades. They matter to investors because these plans provide a legal defense against insider‑trading accusations and create predictable insider trading patterns that can help signal whether sales are routine portfolio management or potentially meaningful to the company’s outlook.

derivative positions financial

"derivativeSummary contains remaining derivative positions (unexercised options, warrants)"

Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Jin Medical International (ZJYL) disclose about Xue Ning in this Form 3?

Jin Medical International discloses that Xue Ning is a director of the company. The Form 3 does not report any non-derivative or derivative equity holdings or insider transactions for Ning in Jin Medical securities.

Are any Jin Medical International (ZJYL) shares reported as owned by Xue Ning?

No Jin Medical shares are reported as owned by Xue Ning in this filing. The Form 3 shows no listed non-derivative or derivative positions and no recorded insider transactions at the time of the report.

Does the Jin Medical International (ZJYL) Form 3 show any recent insider trades by Xue Ning?

The Form 3 shows no insider trades by Xue Ning. All transaction counters, including buys, sells, exercises, gifts, and tax withholdings, are zero, indicating no reportable transactions in this statement.

What role does reporting person Xue Ning hold at Jin Medical International (ZJYL)?

Reporting person Xue Ning is identified as a director of Jin Medical International Ltd. The filing does not indicate that Ning is an officer or a ten percent owner of the company.

Does the Jin Medical International (ZJYL) Form 3 include any derivative securities for Xue Ning?

No derivative securities are listed for Xue Ning in this Form 3. The derivativeSummary section is empty, and the filing reports zero derivative transactions or remaining derivative positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

XUE NING

(Last) (First) (Middle)

C/O JIN MEDICAL INTERNATIONAL LTD.

NO. 33 LINGXIANG ROAD, WUJIN DISTRICT

(Street)

CHANGZHOU JIANGSU

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/16/2026

3. Issuer Name and Ticker or Trading Symbol
Jin Medical International Ltd. [ ZJYL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ NING XUE	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)